Case Presentation #1

Similar documents
2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics

STEMI ST Elevation Myocardial Infarction

CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD. Teo et al, Canadian Journal of Cardiology 2014;30:

Antonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017

J. Schwitter, MD, FESC Section of Cardiology

I Was Too Late With Device Placement


New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

Cardiologic history. Anamnesis. Female BD Risk factors HTN, DM, Dyslipidaemia. Cardiologic Long history. Last admission Heart failure

Lessons learned From The National PCI Registry

Coronary stenting: the appropriate use of FFR

Complicated PTCA of Left Main Total Occlusion in NSTEMI

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Interventions in the Elderly

CASE from South Korea

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

Bifurcation stenting with BVS

National Intervention Council

That unprotected LM: To STENT or NOT to STENT. Vasilios Papademetriou, MD Professor of Medicine Georgetown University

Difficult Data Definitions and Scenario s

Excimer Laser for Coronary Intervention: Case Study RADIAL APPROACH: CORONARY LASER ATHERECTOMY FOR CTO OF THE LAD FOLLOWED BY PTCA NO STENTING

Coronary interventions

Post-Procedure Care and Same-Day PCI. Arnold Seto, MD, MPA

Percutaneous Coronary Intervention: Update

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Flexibility of the COMBO Dual Therapy Stent

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

LM stenting - Cypher

Chronic Total Occlusion: A case for coronary artery bypass grafting

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Stable Angina: Indication for revascularization and best medical therapy

Quinn Capers, IV, MD

Percutaneous coronary intervention of RIMA. The real challenge!

Clopidogrel and ASA after CABG for NSTEMI

Managing the Low Output Low Gradient Aortic Stenosis Patient

Benefit of Performing PCI Based on FFR

Fractional Flow Reserve. A physiological approach to guide complex interventions

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Unprotected LM intervention

Coronary Artery Disease: Revascularization (Teacher s Guide)

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

Assessing Myocardium at Risk: Applying SYNTAX

Percutaneous Mechanical Circulatory Support Devices

Multiple PCI of SVG-LAD and SVG-OM graft vessel in a Bangladeshi patient starting 7 years after

Between Coronary Angiography and Fractional Flow Reserve

Catheter selection for transradial angiography and intervention

Current Management of Coronary Artery Disease with Special Emphasis on the Elderly and Diabetic

Case Presentations TAVR: The Good Bad and The Ugly

What do the guidelines say?

Robotic & Hybrid Coronary Revascularization

APPENDIX F: CASE REPORT FORM

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

2/26/2013. Appropriateness Use Criteria (Drilldown) Disclosures. Tony Hermann has nothing to disclose. Mark Hutcheson has nothing to disclose

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization

Case Review: Borderline LM with IVUS and FFR. Ravi Ramana, DO Heart Care Centers of Illinois SCAI Annual Conference 2010

Ventricular Arrhythmias

Frans Van de Werf, MD, PhD Leuven, Belgium

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Left Main Intervention: Will it become standard of care?

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

NCVD-PCI Registry. Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association of Malaysia

Percutaneous Intervention of Unprotected Left Main Disease

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Form 4: Coronary Evaluation

Cardiogenic Shock in Acute MI

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Revascularization Strategies in Patients with Severe LV Dysfunction

Stress Echo Cases Sunday, October 8, :10 3:30 PM 20 min

Count Down to COMBAT

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Richard Grocott Mason

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Surgery Interesting Cases

Left Main Intervention: Where are we in 2015?

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

was admitted to the Cardiology Service at the from Y /M /D to Y / M / D under the care of Dr..

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

CABG for ischemic cardiomyopathy, post myocardial infarction and cardiogenic shock

Who is the high risk patient?

Lésions du tronc commun: Reste t il une place pour la chirugie? Pierre Deharo, CHU TIMONE, Marseille

OCT guidance for distal LM lesions

Form 4: Coronary Evaluation

Clinical Appropriateness Guidelines: Percutaneous Coronary Intervention

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

Clinical case in perspective. Cases from Poland

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology

TEE guided TAVR using BASILICA technique in patient with stenotic Freestyle aortic bioprosthesis

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

2017 Cardiology Survival Guide

CABG Surgery following STEMI

Transcription:

Case Presentation #1 SCAI Fellows Course December 7, 2013 Barry F Uretsky, MD University of Arkansas for Medical Sciences Central Arkansas Veterans Health System Little Rock, AR

Case Presentation #1 65 yo M s/p CABG PDA and OM 2007 with both grafts known to be occluded, EtOHism, HTN, DM, LV dysfct (EF 20%). Spent 5 of last 6 months in hospital with resp infection progressing to ARDS. Discharged from hosp 5 weeks PT current admission. Presented with heart failure after 5 wk hx of CCS III angina.

Catheterization Findings 95% ostial left main 100% RCA 100% OM 100% SVG to PDA and OM SYNTAX score= 41 STS score= 9.6%

Aortography performed in preparation of possible PCI with Impella

Treatment Plan Reviewed by Heart Team. Surgeons refused to operate primarily because of co morbidities and relative malnutrition.

Treatment Plan Reviewed by Heart Team. Reviewed by Heart Team. Surgeons refused to operate primarily because of co morbidities and relative malnutrition. Plan was to perform stenting of left main under LV assist (Impella) support.

Impella Insertion Preclose technique utilized for percutaneous closure. Device would not pass easily through iliac artery despite previous angiogram showing patent vessel.

Impella Insertion Preclose technique utilized for percutaneous closure. Device would not pass easily through iliac artery despite previous angiogram showing patent vessel. Short 14Fr sheath exchanged for 30 cm 14 Fr sheath and Impella passed followed by aortogram from right femoral access to assure no vascular trauma.

LM BA under Impella Support

3.0x12 mm BA 4.0x12 mm BA 4.0x12 mm EES LM Stenting IVUS: MLA 12.6 mm 2 MLD 4.1 mm

Final Result

Follow Up 4 mos post PCI: Feeling great! No chest pain, increasing daily activities.

Lessons from Case Study CAD patients often have PVD. Prior to Impella insertion, angiography should be used to assure reasonable chance of placement. Be prepared to intervene if there are peripheral complications. Maximize safety net even with easy LM lesions.

Case Presentation # 2 SCAI Fellows Course December 7, 2013 Barry F Uretsky, MD University of Arkansas for Medical Sciences Central Arkansas Veterans Health System Little Rock, AR

Case Presentation #2 43 yo military veteran with 3 wk hx of exertional CP with minimal exertion. Hx of somatoform pain disorder, requiring cane, for ambulation and use of wheel chair at times. Nuclear stress test : large anteroseptal reversible defect

Catheterization Findings 95% bifurcation left main 80% RCA SYNTAX Score= 14 STS Score= 0.2%

Treatment Plan Reviewed by Heart Team. Surgeons agreed to operate. Pt had LIMA to LAD, SVG to OM, and RIMA to RCA.

Follow up Pt was asymptomatic for first 6 mos after CABG but then developed angina for past one month. Meds: ASA 81 mg Metoprolol 50 mg bid ISMN 30 mg qd Simvastatin 40 mg qd Methadone 10 mg tid prn pain

Catheterization Findings 95% bifurcation left main 80% RCA LIMA to D1: patent SVG to OM: patent RIMA to PDA: occluded

Treatment Plan? a) PCI of LM b) PCI of RCA c) PCI of RCA and LM d) Increase Med Rx e) Other

Rx Plan: FFR guided PCI

FFR = 0.84

FFR 0.86

FFR 0.72

Final Result

Final Result FFR post PCI= 0.98

Lessons from Case Study Patent grafts do not ensure complete revascularization. FFR valuable to determine culprit lesion post CABG.

Case Presentation # 3 SCAI Fellows Course December 7, 2013 Barry F Uretsky, MD University of Arkansas for Medical Sciences Central Arkansas Veterans Health System Little Rock, AR

Case Presentation #2 58 yo man without med hx. Recreational cocaine user, last time 3 d PTA. 30 min of severe chest pain. ECG in ambulance showed ST elevation in ant leads. Transmitted to ED. Cath Lab activated. PE: BP 120/100; HR 120/min RR:30/min. Wheezing, in pulm edema. Time sequence: 6:00 ECG in ambulance 6:07 Cath team activated 6:12 Arrival in ED ED Care including intubation 6:57 Arrival in Cath Lab 7:08 Access 7:16 First balloon inflation

First Fluoroscopy (7:14)

What to Do? Right coronary angiography Immediate balloon angioplasty IABP Impella CABG Other

Immediate balloon angioplasty (7:16)

After Stenting (LM to Circumflex)

Final Result (after FKS and IVUS)

RCA

ECG in Cath Lab Immediately before PCI 48 min after PCI

Follow Up Echo later the same day estimated ejection fraction at 10% Patient maintained BP; in fact, became hypertensive requiring diuretic (then became hypotensive) Heart rate gradually decreased to normal range. Patient extubated 24 hours later

Lessons from Case Study 30 50% of patients with ACS from LM die during hospitalization but..

Lessons from Case Study 30 50% of patients with ACS from LM die during hospitalization but.. 50% or so can be salvaged.

Lessons from Case Study 30 50% of patients with ACS from LM die during hospitalization but.. 50% or so can be salvaged. Time is crucial. Plan strategy to utilize the small window most effectively.